Curis (CRIS) Stock: Buy, Sell, or Hold?
CRIS - Curis Inc
$0.39
-0.02 (-4.59%)
▼
5d:
-5.11%
30d:
-56.07%
90d:
-91.76%
HOLD
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
11d
Get Alerted When CRIS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRIS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRIS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRIS is currently trading at $0.39, which is considered oversold relative to its 30-day fair value range of $0.51 to $0.97.
Technical Outlook: Technically, CRIS is in a downtrend. Immediate support is located at $0.33, while resistance sits at $0.69. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: CRIS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $42.67 (+10945.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRIS is in a downtrend. Immediate support is located at $0.33, while resistance sits at $0.69. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: CRIS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $42.67 (+10945.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.51 -
$0.97
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 10945.0% below Wall St target ($42.67)
- CAUTION: Bottoming setup, but lagging the sector by 40% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-5.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.51 -
$0.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.33
Resistance Level
$0.69
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.06
Wall Street Target
$42.67
(+10945.0%)
Revenue Growth (YoY)
-66.0%
Share & Embed Analysis
Last updated: October 24, 2026 2:38 AM ET
Data refreshes hourly during market hours. Next update: 3:38 AM
Data refreshes hourly during market hours. Next update: 3:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRIS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 43 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$37 | 59 HOLD |
